166 related articles for article (PubMed ID: 17242769)
41. The history of the disease called lupus.
Potter B
J Hist Med Allied Sci; 1993 Jan; 48(1):80-90. PubMed ID: 8432972
[No Abstract] [Full Text] [Related]
42. Optimal use of antimalarials in treating cutaneous lupus erythematosus.
Wozniacka A; McCauliffe DP
Am J Clin Dermatol; 2005; 6(1):1-11. PubMed ID: 15675885
[TBL] [Abstract][Full Text] [Related]
43. [Systemic lupus erythematosus].
Fischer-Betz R; Herzer P; Schneider M
Dtsch Med Wochenschr; 2005 Oct; 130(43):2451-8; quiz 2459-60, 2461-2. PubMed ID: 16240245
[No Abstract] [Full Text] [Related]
44. [Evidence-based practice in the management of systemic lupus erythematosus].
Yang XY
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):562-3. PubMed ID: 15355655
[No Abstract] [Full Text] [Related]
45. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
[TBL] [Abstract][Full Text] [Related]
46. Treatment of systemic lupus erythematosus.
Miller ML
Curr Opin Rheumatol; 1992 Oct; 4(5):693-9. PubMed ID: 1419504
[TBL] [Abstract][Full Text] [Related]
47. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
48. Therapy of cutaneous lupus erythematosus.
Callen JP
Med Clin North Am; 1982 Jul; 66(4):795-805. PubMed ID: 7098619
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
Hejazi EZ; Werth VP
Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
[TBL] [Abstract][Full Text] [Related]
50. Management of lupus erythematosus: recent insights.
Wallace DJ
Curr Opin Rheumatol; 2002 May; 14(3):212-9. PubMed ID: 11981315
[TBL] [Abstract][Full Text] [Related]
51. Management of antimalarial-refractory cutaneous lupus erythematosus.
Callen JP
Lupus; 1997; 6(2):203-8. PubMed ID: 9061669
[No Abstract] [Full Text] [Related]
52. Fumaric acid esters: a new therapeutic option for skin manifestations in lupus erythematosus?
Kuhn A; Landmann A; Bonsmann G
Br J Dermatol; 2017 Feb; 176(2):301-302. PubMed ID: 28244075
[No Abstract] [Full Text] [Related]
53. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.
Wozniacka A; Carter A; McCauliffe DP
Lupus; 2002; 11(2):71-81. PubMed ID: 11958581
[TBL] [Abstract][Full Text] [Related]
54. The immunopathology of cutaneous lupus erythematosus.
Kirchhof MG; Dutz JP
Rheum Dis Clin North Am; 2014 Aug; 40(3):455-74, viii. PubMed ID: 25034156
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
Stannard JN; Kahlenberg JM
Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
[TBL] [Abstract][Full Text] [Related]
56. Drug-induced lupus erythematosus.
Marzano AV; Tavecchio S; Menicanti C; Crosti C
G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
[TBL] [Abstract][Full Text] [Related]
57. Treatment of subacute cutaneous lupus erythematosus.
Furner BB
Int J Dermatol; 1990 Oct; 29(8):542-7. PubMed ID: 2242940
[No Abstract] [Full Text] [Related]
58. Treatment of cutaneous lesions in patients with lupus erythematosus.
Callen JP
Dermatol Clin; 1994 Jan; 12(1):201-6. PubMed ID: 8143382
[TBL] [Abstract][Full Text] [Related]
59. What's new in the management of lupus since 2000?
Wallace DJ
J Clin Rheumatol; 2006 Dec; 12(6):307-13. PubMed ID: 17149066
[No Abstract] [Full Text] [Related]
60. A case of discoid lupus erythematosus cured by synthetic antimalarials.
ROUSSET J
Bull Soc Fr Dermatol Syphiligr; 1954; 61(4):380. PubMed ID: 13219573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
